• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ACADIA Pharmaceuticals Inc

+ Add to Watchlist


24.7900 USD 0.8800 3.43%

As of 12:43:15 ET on 09/30/2014.

Snapshot for ACADIA Pharmaceuticals Inc (ACAD)

Open: 25.7100 Day's Range: 24.4600 - 25.7810 Volume: 684,742
Previous Close: 25.6700 52wk Range: 15.6400 - 32.0000 1-Yr Rtn: -9.68%

Stock Chart for ACAD

No chart data available.
  • ACAD:US 24.7753
  • 1D
  • 1M
  • 1Y
Interactive ACAD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACAD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6600
Est. EPS (USD) (12/2014) -0.8640
Est. PEG Ratio -
Market Cap (M USD) 2,472.98
Shares Outstanding (M) 99.44
30 Day Average Volume 1,327,777
Price/Book (mrq) 7.0368
Price/Sale (ttm) 6,716.9190
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACAD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACAD

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Uli HacksellPresident/CEOStephen R Davis "Steve"Exec VP/CFO/Chief Bus Ofcr
Terrence O MooreExec VP/Chief Commercial OfficerRoger M MillsExec VP:Dev/Chief Medical Ofcr
More Company Profile & Key Executives for ACAD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil